Evidence supporting the use of: Protease Inhibitors
For the health condition: Infection (viral)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Protease inhibitors are a well-established class of antiviral drugs, particularly used in the treatment of infections caused by viruses such as HIV and Hepatitis C virus (HCV). These medications work by blocking the action of viral protease enzymes, which are essential for the maturation and replication of the virus. By inhibiting these enzymes, protease inhibitors prevent the virus from producing infectious viral particles, thereby reducing viral load in the patient's body.

In the context of HIV, protease inhibitors have been a cornerstone of antiretroviral therapy since the mid-1990s. Multiple large-scale, randomized controlled trials and long-term cohort studies have demonstrated their effectiveness in reducing morbidity and mortality associated with HIV/AIDS. Similarly, in HCV, combinations including protease inhibitors have significantly increased cure rates and shortened treatment duration, as shown in numerous clinical studies.

The use of protease inhibitors is supported by extensive scientific validation, including FDA approval for specific indications and inclusion in international treatment guidelines. Their mechanism of action is well-understood at the molecular level, and their clinical benefits are substantiated by decades of research. Thus, their use in treating viral infections like HIV and HCV is highly evidence-based.

More about Protease Inhibitors
More about Infection (viral)

Other health conditions supported by Protease Inhibitors

Acquired Immune Deficiency Syndrome
Hepatitis
Infection (viral)

Products containing Protease Inhibitors

We currently have no products on Vitabase that contain this ingredient.